GeoVax, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire GeoVax, Inc.
Quantité totale PI 39
Rang # Quantité totale PI 36 960
Note d'activité PI 2,3/5.0    23
Rang # Activité PI 34 681
Parent Geovax Labs, Inc
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

15 3
3 0
17 0
1
 
Dernier brevet 2024 - Compositions and methods for gen...
Premier brevet 2010 - Eliciting immune responses using...
Dernière marque 2015 - GEDEPTIN
Première marque 2009 - GEOVAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Pan-betacoronavirus vaccines and uses thereof. Provided herein are recombinant modified vaccinia ...
2023 Invention Compositions and methods for generating an immune response to treat or prevent malaria. Plasmodiu...
Invention Replication-deficient modified vaccinia ankara (mva) expressing marburg virus glycoprotein (gp) a...
Invention Viral constructs for use in enhancing t-cell priming during vaccination. The invention provides ...
2022 Invention Immuno-oncology compositions and methods for use thereof. The compositions and methods are descr...
Invention Vaccines and uses thereof to induce an immune response to sars-cov2. Provided herein are recombi...
Invention Vaccinia viral vectors encoding chimeric virus like particles. The compositions and methods are d...
Invention Compositions and methods for generating an immune response to treat or prevent malaria. The compo...
Invention Viral constructs for use in enhancing t-cell priming during vaccination. The invention provides v...
Invention Marburg virus glycoprotein (gp) and matrix protein (vp40). Lassa virus) in the subject to which t...
2021 Invention Cancer vaccine compositions and methods for use thereof. The compositions and methods are descri...
Invention Multivalent hiv vaccine boost compositions and methods of use. Compositions and methods of use ar...
Invention Vaccines and uses thereof to induce an immune response to sars-cov2. Provided herein are recombin...
2020 Invention Methods for generating a zikv immune response utilizing a recombinant modified vaccina ankara vec...
Invention Cancer vaccine compositions and methods for use thereof. The compositions and methods are describ...
2018 Invention Methods and compositions for generating an immune response to treat or prevent malaria. The compo...
Invention Immuno-oncology compositions and methods for use therof. The compositions and methods are describ...
Invention Compositions and methods for generating an immune response to lasv. Compositions and methods are...
Invention Compositions and methods for generating an immune response to lasv. ArenavirusLassa virusLassa vi...
2017 Invention Compositions and methods for generating an immune response to hepatitis b virus. The compositions...
Invention Compositions and methods for generating an immune response to a flavivirus. The compositions and...
Invention Compositions and methods for generating an immune response to a flavivirus. The compositions and ...
Invention Compositions and methods for generating an immune response to a tumor associated antigen. The com...
2016 Invention Replication-deficient modified vaccinia ankara (mva) expressing ebola virus glycoprotein (gp) and...
Invention Compositions and methods for generating an immune response to a hemorrhagic fever virus. The comp...
2015 P/S Pharmaceutical products for [ the treatment of viral and infectious diseases, for ] the treatment...
2014 Invention Combination therapy for treating viral reservoirs. Compositions and methods are provided for redu...
Invention Method of increasing immune response to hiv antigens. The present invention is directed to method...
2012 Invention Mva vectors expressing polypeptides and having high level production in certain cell lines. The ...
Invention Mva vectors expressing polypeptides and having high level production in certain cell lines. The p...
2011 Invention Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response....
2010 Invention Eliciting immune responses using recombinant mva viruses expressing hiv env, gag and pol anitgens...
2009 P/S Pharmaceutical preparations excluding those for sanitary purposes; medicines and vaccines for the...
P/S manufacture of medicines and vaccines for others research, testing and development of medicines a...
P/S Pharmaceutical preparations; medicines and vaccines for prevention and/or treatment of infectious...